ALHC:NSD-Alignment Healthcare LLC (USD)

COMMON STOCK | Healthcare Plans | NSD

Last Closing Price

USD 10.98

Change

-0.62 (-5.34)%

Market Cap

USD 2.06B

Volume

0.22M

Avg Analyst Target

USD 16.75 (+52.55%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

ALHC Stock Forecast & Price:
Based on the Alignment Healthcare LLC stock forecasts from 7 analysts, the average analyst target price for Alignment Healthcare LLC is USD 16.75 over the next 12 months. Alignment Healthcare LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alignment Healthcare LLC is Slightly Bullish , which is based on 7 positive signals and 4 negative signals. At the last closing, Alignment Healthcare LLC’s stock price was USD 10.98. Alignment Healthcare LLC’s stock price has changed by -6.95% over the past week, -0.45% over the past month and -54.72% over the last year.

About Alignment Healthcare LLC (ALHC:NSD)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantag ...Read More

Company Website : https://www.alignmenthealthcare.com

Address : 1100 West Town and Country Road, Orange, CA, United States, 92868

Employees : 847

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

52 Week High : 23.50

Short Ratio : 8.65

52 Week Low : 6.14

Shorted Shares : 3,296,627

200 Day Moving Average : 12.77

Shorted Shares Previous Month : 3,455,281

50 Day Moving Average : 10.40

Shares Held By Insiders : 6.73%

Short Percentage : 4.05%

Shares Held by Institutions : 83.02%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-06-28 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MGLN Magellan Health Inc

N/A

 USD2.50B 8.49 16.66
CLOV Clover Health Investments Corp

-0.16 (-6.64%)

 USD1.06B N/A N/A

ETFs Containing ALHC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.91% 100% A+ 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.91% 100% A+ 50% F
Trailing 12 Months  
Capital Gain -52.86% 100% A+ 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -52.86% 100% A+ 34% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -11.23% 100% A+ 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.23% 100% A+ 17% F
Risk Return Profile  
Volatility (Standard Deviation) 22.45% 100% A+ 68% D+
Risk Adjusted Return -50.01% 100% A+ 15% F
Market Capitalization 2.06B 100% A+ 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 7.53 50% F 10% F
Price / Cash Flow Ratio -26.10 100% A+ 84% B
EV/EBITDA 409.08 100% A+ 2% F
Management Effectiveness  
Return on Equity -55.36% 100% A+ 22% F
Return on Invested Capital -56.40% 100% A+ 18% F
Return on Assets -15.26% 100% A+ 26% F
Debt to Equity Ratio 49.21% 50% F 40% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 8.65 50% F 11% F
Short Percent 4.05% 100% A+ 42% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

New Post

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.